Your session is about to expire
← Back to Search
CARE Model Therapy for Stuttering
N/A
Recruiting
Led By Courtney T Byrd, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11-weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing online therapy sessions and specialized training for speech therapists to help people who stutter. It focuses on both monolingual and multilingual speakers. The goal is to improve their speech fluency by addressing various factors like speech patterns, language skills, and psychological aspects.
Who is the study for?
This trial is for children (2-17 years) and adults (18+ years) who stutter. Eligible participants are those recognized by caregivers or self-reported as individuals who stutter, have been diagnosed by a speech-language pathologist, or show a certain level of disfluency in their speech.
What is being tested?
The study is examining the Blank Center CARE Model(TM), focusing on how it can help people who stutter. It looks at contributions to stuttering and evaluates telehealth treatments and training methods for fluency disorders.
What are the potential side effects?
Since this trial involves non-medical interventions like speech therapy, there aren't typical medical side effects; however, participants may experience fatigue or frustration during treatment sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 11-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11-weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Advocacy
Communication Competence
Education
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)Experimental Treatment1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stuttering, particularly those involving speech-language pathology and telehealth, focus on improving fluency by addressing speech, language, and psychosocial factors. These treatments often include techniques such as controlled fluency shaping, which helps patients develop smoother speech patterns, and stuttering modification, which aims to reduce the severity and frequency of stuttering episodes.
Additionally, cognitive-behavioral therapy (CBT) is used to address the anxiety and negative emotions associated with stuttering. The use of telehealth allows for greater accessibility and consistency in treatment, which is crucial for sustained improvement.
These mechanisms are important for stuttering patients as they not only improve speech fluency but also enhance overall communication skills and reduce the psychological burden of stuttering.
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
378 Previous Clinical Trials
83,609 Total Patients Enrolled
Courtney T Byrd, PhDPrincipal InvestigatorThe University of Texas at Austin
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Criterion: Adults aged 18 and older who stutter and have received a formal diagnosis from a certified speech-language pathologist, or show specific stuttering-like behaviors during speech, or have a high score on a stuttering severity test.My child, aged 2-17, shows signs of stuttering and meets the study's criteria.
Research Study Groups:
This trial has the following groups:- Group 1: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.